GFR Calculator (USA)
Calculate your estimated Glomerular Filtration Rate (eGFR) using the CKD-EPI equation, the gold standard for kidney function assessment in USA.
CKD-EPI Equation for eGFR
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation estimates eGFR:
- Variables: SCr = Serum Creatinine, k = Constant (0.7 for females, 0.9 for males), a = -0.329 for females, -0.411 for males
- Constants: 141, 1.209, 0.993, 1.018 (female multiplier), 1.159 (black multiplier)
- Validation: More accurate than MDRD, especially at higher GFR values
Calculator: eGFR Assessment
Kidney Function Visualization
eGFR Stage
CKD Stages
Kidney Health Assessment & Recommendations
- Maintain healthy lifestyle habits
- Stay hydrated and avoid nephrotoxic substances
- Control blood pressure (target <130/80 mmHg)
- Regular monitoring every 6-12 months
Understanding eGFR and Kidney Health
Estimated Glomerular Filtration Rate (eGFR) measures how well your kidneys filter waste from your blood. It's calculated from your serum creatinine level and adjusted for age, sex, and race. Normal eGFR is ≥90 mL/min/1.73m².
The CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation is the preferred method for estimating GFR in the USA. It was developed to provide more accurate estimates, especially in the normal-to-mildly decreased GFR range (≥60 mL/min/1.73m²), compared to the older MDRD equation.
The equation accounts for non-linear relationship between creatinine and GFR, providing improved accuracy across the entire range of kidney function.
According to KDIGO (Kidney Disease: Improving Global Outcomes) 2012 guidelines:
- CKD Diagnosis: eGFR <60 mL/min/1.73m² for ≥3 months OR kidney damage markers
- Staging: Based on eGFR and albuminuria categories
- Monitoring: Frequency depends on CKD stage and progression risk
- Referral: Nephrologist referral recommended for eGFR <30 or rapid decline
eGFR Knowledge Quiz
Which eGFR value indicates Stage 3b CKD (Moderate-Severe reduction in kidney function)?
Stage 3b CKD corresponds to eGFR 30-44 mL/min/1.73m². This represents moderate to severe reduction in kidney function and requires closer monitoring and intervention.
CKD staging is crucial for determining appropriate management. Stage 3b patients should be evaluated for complications and consider nephrology referral.
What is the primary advantage of the CKD-EPI equation over the MDRD equation?
The CKD-EPI equation is more accurate than MDRD, especially at higher GFR values (≥60 mL/min/1.73m²). It better reflects the non-linear relationship between creatinine and GFR.
The improved accuracy of CKD-EPI helps identify more patients with early-stage CKD who may benefit from intervention.
At what eGFR threshold should a patient be considered for nephrology referral?
Nephrology referral is recommended when eGFR <30 mL/min/1.73m² (Stage 4 or 5 CKD) or with rapid decline. Earlier referral may be considered for complex cases.
Early nephrology involvement can improve outcomes and prepare for renal replacement therapy if needed.
What defines chronic kidney disease according to KDIGO guidelines?
CKD is defined as abnormalities of kidney structure or function present for >3 months, with implications for health. This includes eGFR <60 mL/min/1.73m² for ≥3 months OR kidney damage markers (albuminuria, structural abnormalities).
Duration of ≥3 months distinguishes CKD from acute kidney injury. Both reduced GFR and evidence of kidney damage qualify for diagnosis.
A 65-year-old Black male with diabetes has an eGFR of 42 mL/min/1.73m² and persistent albuminuria. How would you classify his CKD stage and what management considerations apply?
This patient has Stage 3b CKD (eGFR 30-44 mL/min/1.73m²). Management should include: aggressive diabetes control, ACE inhibitor or ARB therapy, blood pressure control (<130/80), dietary protein restriction, cardiovascular risk reduction, and potential nephrology referral. Close monitoring for progression is essential.
Patients with both diabetes and CKD require intensified management due to high cardiovascular risk. Albuminuria indicates ongoing kidney damage requiring specific interventions.
Q&A
Q: My eGFR came back as 52 mL/min/1.73m². What does this mean for my health?
A: An eGFR of 52 mL/min/1.73m² places you in Stage 3a CKD (mild to moderate reduction in kidney function). This means your kidneys are filtering about half as much blood as normal.
Recommended Actions:
- Monitor: Regular follow-up every 3-6 months to track progression
- Blood Pressure: Target <130/80 mmHg with ACE inhibitors if needed
- Medications: Review all medications for kidney safety
- Lifestyle: Healthy diet, controlled diabetes/blood pressure if present
- Referral: Consider nephrology consultation if rapid decline occurs
Many people with Stage 3a CKD can maintain stable function with proper management. Early intervention can slow progression and reduce cardiovascular risk.
Q: When should I use the CKD-EPI equation versus the MDRD equation for eGFR calculation?
A: The CKD-EPI equation is now the preferred method for eGFR estimation in the USA according to clinical guidelines. Here's when to use each:
CKD-EPI (Preferred):
- General population: More accurate across all GFR ranges
- Normal to mildly reduced GFR: Better precision than MDRD
- New assessments: Standard of care since 2012 guidelines
- Drug dosing: Many dosing guidelines updated for CKD-EPI
MDRD (Historical):
- Historical comparisons: When comparing to older lab results
- Specific protocols: Some transplant centers still use MDRD
The CKD-EPI equation has superior performance characteristics and is recommended by KDIGO and other major organizations.
Q: I have diabetes and my eGFR is 65 mL/min/1.73m². Should I be concerned?
A: An eGFR of 65 mL/min/1.73m² represents Stage 2 CKD (mild decrease in kidney function). For diabetic patients, this requires attention as diabetes is the leading cause of kidney disease.
Management Priorities:
- HbA1c Control: Target <7% (individualized based on patient factors)
- ACE/ARB Therapy: Protects kidneys even with mild dysfunction
- Albuminuria Check: Test for protein in urine annually
- Blood Pressure: Aggressive control (<130/80 mmHg)
- Monitoring: eGFR every 6 months to watch for progression
Early intervention with diabetes management and kidney-protective medications can prevent or slow progression to more severe CKD stages. This is an opportunity to optimize your long-term kidney health.